Craft

Sanofi

Stock Price

€92.4

2024-07-19

Market Capitalization

€113.8 B

2024-06-25

Revenue

€43.1 B

FY, 2023

Sanofi Summary

Company Summary

Overview
Sanofi is a global healthcare company engaged in the research, development, manufacture, and marketing of therapeutic solutions. It operates in three core business units: Specialty Care, Vaccines, and General Medicines. The Specialty Care business unit focuses on rare diseases, multiple sclerosis, oncology, immunology, and rare blood disorders. The Vaccines business unit primarily operates through Sanofi Pasteur, a key supplier of life-saving vaccines in both developed and emerging markets. The General Medicines business unit offers treatments for diabetes, cardiovascular, as well as established products. The company also comprises Consumer Healthcare (CHC), a standalone business unit with integrated research, development, manufacturing, support, and information technology capabilities.
Type
Public
Status
Active
Founded
2004
HQ
Paris, FR | view all locations
Website
https://www.sanofi.com/
Cybersecurity rating
ESG rating
60-79 out of 100|View all ESG data
Sectors

Key People

  • Paul Hudson

    Paul Hudson, Chief Executive Officer & Director

  • Serge Weinberg

    Serge Weinberg, Chairman of the Board of Directors

  • Olivier Charmeil

    Olivier Charmeil, Executive Vice President, General Medicines

  • Natalie Bickford

    Natalie Bickford, Executive Vice President, Chief People Officer

Operating MetricsView all

Phase II Trials Products (Oncology)

12
100.0%

FY, 2021

Phase III/Filed Trials Products (Oncology)

2
66.7%

FY, 2021

Phase I Trials Products (Rare Blood Disorders)

4

FY, 2020

LocationsView all

119 locations detected

  • Paris, IDF HQ

    France

    54 Rue la Boétie

  • Bridgewater Township, NJ

    United States

    55 Corporate Drive

  • Hydra, Algiers Province

    Algeria

    29, 30, 31 Micro Zone d’activités Batiment B

  • Macquarie Park, NSW

    Australia

    Building D, 12-24 Talavera Road

  • Wien, Wien

    Austria

    Turm A, 29. OG Wienerbergstraße 11

  • Dhaka, Dhaka Division

    Bangladesh

    6/2 Segun Bagicha Rd

and 113 others

Sanofi Financials

Summary Financials

Revenue (Q1, 2024)
€10.5B
Gross profit (Q1, 2024)
€8.1B
Net income (Q1, 2024)
€1.2B
Cash (FY, 2023)
€8.7B
EBIT (Q1, 2024)
€1.4B
Enterprise value
$123.5B

Footer menu